Literature DB >> 16338585

Chlamydia trachomatis persistence: an update.

Philomène Mpiga1, Madeleine Ravaoarinoro.   

Abstract

Chlamydial persistence is a reversible state generated during conditions deleterious to growth. In persistence, Chlamydia trachomatis remains viable but atypical, with an enlarged, aberrant form and quiescent metabolism. It favours chronic chlamydiosis, leading to serious sequelae. Although the mechanism of persistence formation is still unknown, more reliable molecular approaches tend to confirm that its occurs in vivo, even lasting 3 years. One approach consists of identifying unprocessed rRNA found only in viable Chlamydia, when infection is not apparent. Another approach, referring to the fact that immunity is type-specific, consists of showing by genotyping that multiple recurrences are due to the same genovar. At the molecular level, persistence is characterized by increased expression of ct755, one of the three heat shock protein (hsp60)-coding genes. In addition, chromosomal replication occurs continuously, and cell division is blocked possibly due to the repression of genes such as ftsW and amiA. At the immunological level, persistence reveals the failure of host-defence mechanisms because of reduced or suppressed pro-inflammatory or cytotoxic responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338585     DOI: 10.1016/j.micres.2005.04.004

Source DB:  PubMed          Journal:  Microbiol Res        ISSN: 0944-5013            Impact factor:   5.415


  30 in total

Review 1.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

2.  Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.

Authors:  K Wolf; H J Betts; B Chellas-Géry; S Hower; C N Linton; K A Fields
Journal:  Mol Microbiol       Date:  2006-09       Impact factor: 3.501

3.  Protective immunity against Chlamydia trachomatis can engage both CD4+ and CD8+ T cells and bridge the respiratory and genital mucosae.

Authors:  Catarina V Nogueira; Xuqing Zhang; Nicholas Giovannone; Erica L Sennott; Michael N Starnbach
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

4.  Detection of Chlamydophila pneumoniae in patients with arthritis: significance and diagnostic value.

Authors:  Carlo Contini; Anastasio Grilli; Lorenzo Badia; Viola Guardigni; Marcello Govoni; Silva Seraceni
Journal:  Rheumatol Int       Date:  2010-04-10       Impact factor: 2.631

5.  Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation.

Authors:  Chris L McGowin; Rae Ann Spagnuolo; Richard B Pyles
Journal:  Infect Immun       Date:  2009-12-07       Impact factor: 3.441

6.  Differences in 23S ribosomal RNA mutations between wild-type and mutant macrolide-resistant Chlamydia trachomatis isolates.

Authors:  Yong Jiang; Hui Zhu; Li-Na Yang; Yuan-Jun Liu; Shu-Ping Hou; Man-Li Qi; Quan-Zhong Liu
Journal:  Exp Ther Med       Date:  2015-06-24       Impact factor: 2.447

7.  Impact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis.

Authors:  Kensuke Shima; Márta Szaszák; Werner Solbach; Jens Gieffers; Jan Rupp
Journal:  Antimicrob Agents Chemother       Date:  2011-02-14       Impact factor: 5.191

8.  Activities of first-choice antimicrobials against gamma interferon-treated Chlamydia trachomatis differ in hypoxia.

Authors:  Kensuke Shima; Matthias Klinger; Werner Solbach; Jan Rupp
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

9.  Competitive inhibition of amino acid uptake suppresses chlamydial growth: involvement of the chlamydial amino acid transporter BrnQ.

Authors:  Peter R Braun; Hesham Al-Younes; Joscha Gussmann; Jeannette Klein; Erwin Schneider; Thomas F Meyer
Journal:  J Bacteriol       Date:  2007-11-16       Impact factor: 3.490

10.  A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication.

Authors:  Dustin L Johnson; Chris B Stone; David C Bulir; Brian K Coombes; James B Mahony
Journal:  BMC Microbiol       Date:  2009-10-14       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.